Excellent - I have rich content from multiple authoritative sources. Here is the comprehensive cause-specific treatment guide:
Hydronephrosis: Cause-Specific Treatment
General Principles Before Specific Therapy
Treatment is dictated by three factors: location of obstruction, underlying cause, and degree of renal impairment.
- Complete bilateral obstruction (or obstruction of a solitary kidney) presenting as AKI is a medical emergency - rapid intervention is required to salvage function
- Short-term obstruction (<1-2 weeks): usually adequate functional return after relief
- Chronic obstruction (>12 weeks): often irreversible and severe kidney damage; recovery may be limited even after relief
- Dialysis is rarely required except to make the patient fit for intervention (e.g., life-threatening hyperkalemia, severe fluid overload)
Key principle: Nephrostomy can be used to gauge potential for functional recovery in chronic obstruction - failure of kidney recovery after several weeks of drainage strongly suggests irreversible structural damage, making definitive surgery unlikely to benefit.
- Comprehensive Clinical Nephrology, 7th ed., p. 861-863
Emergency / Temporizing Measures (Any Cause)
Before definitive treatment, urgent decompression may be needed when:
- Obstruction with infection (pyonephrosis/urosepsis)
- AKI or azotemia from obstruction of solitary or bilateral kidneys
- Severe unrelenting pain
| Approach | When to Use |
|---|
| Percutaneous nephrostomy (PCN) | First-line emergency for upper urinary tract obstruction; achievable under local anesthetic; avoids general anesthesia; decompresses >70% without dialysis |
| Retrograde ureteral stent | Upper tract obstruction; requires cystoscopy (usually GA); preferred over PCN in grade 1-2 ureteral injuries |
| Urethral catheter | Obstruction distal to the bladder (BPH, urethral stricture) |
| Suprapubic cystostomy | When urethral catheter cannot be passed |
In bilateral obstruction: place nephrostomy in the kidney with more preserved parenchyma first; bilateral nephrostomies may be required to maximize functional recovery.
- Comprehensive Clinical Nephrology, 7th ed., p. 862
1. Pelviureteric Junction (PUJ) Obstruction
Most common cause of unilateral hydronephrosis (incidence 1:500 live births)
Indications for Surgery
- Functionally significant PUJ obstruction (confirmed on diuretic renography or MRU)
- Pre-operative drainage (stent or nephrostomy) only in select cases: infection, azotemia from solitary/bilateral obstruction, or severe pain
Definitive Surgery: Anderson-Hynes Dismembered Pyeloplasty
- Gold standard - success rate ~95%
- Works regardless of whether ureteral insertion is high or dependent
- Allows: reduction of redundant pelvis, excision of adynamic/dysplastic segment, preservation of crossing lower pole vessels (ureter anastomosed anterior to vessel)
- Ureter spatulated along its lateral border; anastomosis with 5-0 or 6-0 absorbable monofilament suture
- Internal ureteral stent placed routinely in adults, removed 4-6 weeks post-op
- External closed suction drain placed near (not on) suture line
Surgical Approaches (equivalent outcomes):
| Approach | Notes |
|---|
| Laparoscopic (transperitoneal or retroperitoneal) | Standard; largely replaced open surgery; less morbidity, comparable long-term outcomes |
| Robotic-assisted | Gaining traction in pediatric patients; reduced complications but high cost |
| Open | Reserved for complex/secondary cases with active inflammation |
Alternatives (inferior outcomes):
- Endopyelotomy or balloon dilation: higher recurrence rate - outcomes inferior to open/laparoscopic pyeloplasty
Other Techniques (historical/niche):
-
Y-V plasty (Foley) - for high ureteric insertion with small pelvis
-
Heineke-Mikulicz reconstruction
-
Davis intubated ureterotomy
-
Hellstrom vascular relocation (for crossing vessel without dismemberment)
-
Campbell-Walsh-Wein Urology, p. 2601-2605; Smith & Tanagho's General Urology, 19th ed.; Comprehensive Clinical Nephrology, 7th ed., p. 863
2. Ureteral Calculi
Most common acquired cause of ureteral obstruction
Treatment involves: relief of pain + elimination of obstruction + treatment of infection
| Stone Size / Location | Treatment |
|---|
| Small stones <5 mm | Medical expulsion therapy (alpha-blockers e.g., tamsulosin) - await spontaneous passage |
| 5-10 mm, uncomplicated | ESWL (extracorporeal shock wave lithotripsy) or ureteroscopy (URS) |
| >10 mm, impacted, or failed ESWL | Ureteroscopy with laser lithotripsy |
| Large staghorn / upper tract stones | Percutaneous nephrolithotomy (PCNL) |
| Obstruction + sepsis | Emergency PCN or retrograde stenting first, then interval stone removal |
Ureteral obstruction by papillary tissue, blood clots, or fungus ball is treated by procedures similar to those for calculi.
- Comprehensive Clinical Nephrology, 7th ed., p. 863
3. Benign Prostatic Hyperplasia (BPH)
Most common cause of lower urinary tract obstruction in males
Conservative (Watchful Waiting)
- Patients with minimal symptoms, no infection, and normal upper urinary tract can be observed until symptoms warrant intervention
Medical Therapy
| Drug Class | Examples | Mechanism |
|---|
| Alpha-1 blockers | Tamsulosin, alfuzosin, silodosin | Relax smooth muscle of prostate/bladder neck; rapid symptom relief |
| 5-alpha reductase inhibitors | Finasteride, dutasteride | Reduce prostate volume; prevent progression; best for large prostates |
| Combination | Alpha-blocker + 5-ARI | Superior to monotherapy for preventing progression (MTOPS/CombAT trials) |
| PDE-5 inhibitors | Tadalafil | Also improves LUTS |
Surgical Therapy
| Procedure | Indication |
|---|
| TURP (gold standard) | Moderate-to-large prostate; refractory to medical therapy |
| Laser enucleation (HoLEP) | Large prostates; less bleeding |
| Open prostatectomy (Millin's) | Very large prostates (>80-100 g) |
| TUNA / TUMT | Minimally invasive; less durable |
- Comprehensive Clinical Nephrology, 7th ed., p. 863; Campbell-Walsh-Wein Urology, p. BPH chapter
4. Carcinoma of Prostate / Bladder / Cervix / Uterus
Malignant ureteric obstruction - often bilateral, poor prognosis
Immediate Decompression
- PCN or retrograde ureteral stent as bridge to treatment
- Metallic stents may provide more durable decompression in malignant ureteric obstruction vs. plastic stents
- Extra-anatomic stents (tunneled percutaneously from kidney to bladder in the abdominal wall): used when conventional stents have failed or ureters are impassable due to disease
Definitive Management
- Treat the underlying malignancy (chemotherapy, radiotherapy, surgery)
- Lymphoma causing obstruction: may respond dramatically to chemotherapy alone
- Long-term stenting or nephrostomy as palliative therapy for those unfit for major surgery or incurable disease
- Ileal conduit (urinary diversion): for patients with extensive pelvic malignancy or radiation damage
A "realistic medicine" approach is important - surgical management of malignant obstruction can reduce quality of life and carries significant complication risks; patient selection is paramount.
- Comprehensive Clinical Nephrology, 7th ed., p. 863
5. Retroperitoneal Fibrosis
Ureters encased in dense fibrous retroperitoneal tissue
| Treatment | Details |
|---|
| Ureteral stenting | Temporizing; long-term adverse effects with chronic stenting |
| Corticosteroids | Relief of obstruction in idiopathic RPF; also for IgG4-related RPF |
| Ureterolysis | Surgical freeing of ureters from fibrous encasement; can be combined with steroid therapy to prevent recurrence |
| Robotic ureterolysis | Available in specialist centers; may offer durable cure preferable to long-term stents + steroids |
In IgG4-related retroperitoneal fibrosis, corticosteroids alone may be sufficient and highly effective.
- Comprehensive Clinical Nephrology, 7th ed., p. 863
6. Urethral Stricture
| Step | Treatment |
|---|
| Acute/emergency | Urethral catheter; if impassable → suprapubic cystostomy |
| Short/mild stricture | Direct-vision internal urethrotomy (DVIU) or dilation |
| Definitive | Urethroplasty (gold standard for longer/recurrent strictures) - onlay graft or excision and primary anastomosis |
| Evolving | Urethral stenting |
Repeated DVIU or dilation has high recurrence rates and is not a definitive solution for most strictures.
- Comprehensive Clinical Nephrology, 7th ed., p. 863
7. Neurogenic Bladder (Spinal Cord Damage)
| Treatment | Details |
|---|
| Clean intermittent catheterization (CIC) | First-line for incomplete bladder emptying; preserves upper tracts |
| Indwelling urethral/suprapubic catheter | For those unable to perform CIC |
| Anticholinergics | Oxybutynin, tolterodine - reduce detrusor overactivity |
| Intravesical botulinum toxin | For refractory neurogenic detrusor overactivity |
| Sacral neuromodulation | Selected cases |
| Urinary diversion | Ileal conduit for severe cases refractory to all measures |
8. Pyonephrosis (Infected Hydronephrosis)
A urological emergency.
- Urgent PCN drainage (or retrograde stenting if feasible)
- IV antibiotics covering gram-negatives (e.g., piperacillin-tazobactam or cephalosporin ± aminoglycoside)
- Stabilize patient; treat sepsis
- Definitive treatment of underlying cause (stone removal, stricture repair, etc.) as interval procedure once infection controlled
9. Ureterocele
- Endoscopic incision (first-line): cystoscopic puncture/incision of the ureterocele
- May cause vesicoureteral reflux post-incision - monitor
- Open surgical reconstruction for complex or failed endoscopic cases
10. Pregnancy-Related Hydronephrosis
- Usually physiological and transient (right side > left due to uterine dextrorotation and right ovarian vein)
- Conservative management - resolves spontaneously post-delivery
- Ureteral stent or PCN only if symptomatic obstruction with infection or significant pain
11. Antenatal Hydronephrosis (ANH)
| Risk Category | Management |
|---|
| Low risk | Postnatal ultrasound at ≥48 hours; repeat US every 1-3 months |
| High risk | VCUG + antibiotic prophylaxis + functional scan (MAG3 diuresis renography after 4-6 weeks) + monthly follow-up |
-
Majority of ANH cases are transient and resolve spontaneously after birth
-
Persistent significant hydronephrosis with confirmed PUJ obstruction and differential function <40%: pyeloplasty
-
Bailey and Love's Surgery, 28th ed., p. 3450-3451
Summary Table
| Cause | Definitive Treatment |
|---|
| PUJ obstruction | Anderson-Hynes dismembered pyeloplasty (laparoscopic/robotic) |
| Ureteric calculus | ESWL / URS / PCNL (size-dependent) |
| BPH | Alpha-blocker → 5-ARI → TURP |
| Malignant obstruction | Stent/PCN + treat primary malignancy |
| Retroperitoneal fibrosis | Ureterolysis + corticosteroids |
| Urethral stricture | DVIU → urethroplasty |
| Neurogenic bladder | CIC / catheter / botox / neuromodulation |
| Pyonephrosis | Emergency PCN + IV antibiotics |
| Ureterocele | Endoscopic incision |
| Pregnancy | Watchful waiting |
| ANH | Risk-stratified surveillance / pyeloplasty if persistent |
Sources: Comprehensive Clinical Nephrology 7th ed., p. 861-863 | Campbell-Walsh-Wein Urology, p. 2601-2605 | Smith & Tanagho's General Urology, 19th ed. | Bailey and Love's Surgery 28th ed., p. 3450